Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeOur CompanyOur societal impact Global Health Equity Treating Children At Risk for Intestinal Worms

      Treating children at risk for intestinal worms

      Intestinal worms infections rob children of vital nutrients and a bright future. By donating deworming medication and supporting hygiene education programs, we are working toward a world where children learn and play, free of intestinal worms.

      More from Johnson & Johnson

      Meet a nurse who leads clinical trials to find innovative cancer therapies

      Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      How robots are helping personalize knee replacement surgery

      For Arthritis Awareness Month, learn the latest about this common procedure and how Johnson & Johnson MedTech is innovating to improve patient outcomes.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.